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Paediatrics
Increasingly in paediatric intensive care, as in the adult
sphere, the intensivist’s focus is increasingly guided
towards not only reducing mortality but also to ensuring
that survival is morbidity-free. Baghurst et al. [1] reported
on the applicability of sequential control charts for
monitoring of the quality of paediatric intensive care
using risk-adjusted probabilities of death estimated by the
Paediatric Index of Mortality version 2 (PIM2). A total of
10,710 patient records submitted to the Australia and New
Zealand Paediatric Intensive Care registry from 8 PICU’s
were used in the report. During the 2-year monitoring
period the investigators demonstrated that their method-
ology was able to detect one ‘alarm’ for poor PICU
performance and one ‘alarm’ for better than expected
PICU performance. In their paper, the authors present a
detailed description of sequential analysis methodologies
and describe their potential prospective use as tools for
monitoring the performance of intensive care units. They
caution that ‘alarms’ for poor or excessively good per-
formance are arbitrarily set and are not necessarily
indicative of ‘real’ problems. Alarms should, however,
act as triggers for investigation to ascertain whether the
data is sound and if so whether true clinical over or
underperformance exists. Numa et al. [2] undertook a
study to determine whether outcomes were influenced by
time of admission to an Australian tertiary paediatric
intensive care unit without 24 h per day in-house
intensivist cover. Evening, night and weekend cover by
staff intensivists was provided mainly by telephone with
discretionary return to hospital to support resident pae-
diatric staff. The authors found that a lack of in-house
intensivist was not associated with any increase in risk-
adjusted mortality or increased length of stay. They
attribute these findings to a combination of relatively
experienced junior staff and the effectiveness of telephone
backup and discretionary attendance from intensivists
after hours. Two studies in 2008 looked at the quality of
survival of children after undergoing intensive care. In a
case-control study, Elison et al. [3] reported on a detailed
neuropsychological follow-up of 16 children, with
mean age 9.44 ± 2.85 years, tested a mean of 4.8 ±
1.4 months following hospital discharge. They detected
the presence of impaired memory and attention in chil-
dren following acute illness and links between memory
anomalies and emotional/behavioural problems. These
findings, if replicated in a larger study, are very important
to children and their parents and teachers. Knoester et al.
[4] also reported on early neurocognitive sequelae of
intensive care but in addition reported information on
physical outcomes. They determined that 69% of children
had detectable physical sequelae 3 months after PICU
discharge. Whilst 30% of sequelae were attributed to
previously unknown illness, 39% were acquired of which
8% were related to complications of PICU procedures.
Finally, in the area of patient safety and quality, Bur-
mester et al. [5] reported on the apparent benefit of the
introduction of a structured prescription education pro-
gramme and standardised prescription template in a
paediatric cardiac ICU. The total number of prescription
errors fell from a baseline of 16.8% of prescriptions to
4.8% after the implementation of the measures and this
was associated with a small but statistically significant
reduction in the incidence of Adverse Drug Events.
Weight-based variations in drug dosing are often quoted
as a factor in the known high incidence of drug errors in
paediatric practice. Disappointingly, tenfold miscalcula-
tions which are particularly common and dangerous in
children if the decimal point is misplaced during calcu-
lations showed no improvement with the studied
interventions. This report highlights the need for regular
ongoing education in critical care units which typically
have high prescription volumes and often see high turn-
over of staff, particularly ‘junior’ prescribers such as
resident medical staff.
The high mortality of septic shock in children was
confirmed in a paper from Wolfler et al. [6] who reported
a prospective observational study across 15 Italian pae-
diatric intensive care units conducted over a period of
1 year. During the study 2,741 children were admitted to
the participating PICU’s. The incidence of severe sepsis
was 1.6% and that of septic shock 2.1%, with associated
mortalities of 17.7 and 50.8%, respectively. In March
2008 the Journal published a landmark paper from
de Oliveira et al. [7]. They studied children with septic
shock who were resuscitated according to ACCM/PALS
guidelines [8] with or without ScvO2 goal-directed ther-
apy. In this randomised controlled trial, there was a
significant difference in mortality rate with use of ACCM/
PALS haemodynamic support guidelines for septic shock
between patients with or without ScvO2 guided therapy.
Patients who received therapies directed to the goal of
ScvO2 [ 70% were given more fluid, red blood cells and
inotropic support after the initial resuscitation, with a
resulting 3.3-fold reduction in mortality. This study sup-
ports the incorporation goal-directed therapy using the
endpoint of a ScvO2 C 70% within ACCM/PALS
guidelines the use of which provided a significant bene-
ficial impact on the outcome of children and adolescents
with septic shock in this study. Recently the use of
vasopressin and vasopressin analogues, potent vasocon-
strictors, has been reported in the management of
vasodilatory shock in children. Jerath reported a retro-
spective study of the use of vasopressin in a series of 157
children in a multidisciplinary PICU. Haemodynamics
appear to have been favourably influenced, but the
authors noted adverse effects on renal function and
lower platelet counts associated with vasopressin use.
Yildizdas et al. [9] performed a randomised non-blinded
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comparison of the use of the vasopressin analogue
terlipressin in a group of 58 children with refractory
septic shock. Although terlipressin had no beneficial
effect on mortality rate in this study, its use was associ-
ated with increased mean arterial pressure, improved
oxygenation, decreased length of stay in the PICU and
had a beneficial effect on survival time among nonsur-
vivors. Despite these interesting early reports, the place of
vasopressin and its analogues in the management of shock
states in children is not yet established. Until blinded,
randomized, and placebo-controlled studies are conducted
in children with septic shock and in other shock states
which compare the use of vasopressin-like drugs to
standard treatments such as noradrenaline, their use
should be considered only a rescue therapy of last resort.
With increased experience, improved surgical tech-
niques, and advances in postoperative care and
immunosuppressive therapy, paediatric intestinal trans-
plantation is already into the medical mainstream. In this
article, Hauser and coll [10] reviewed the literature on
intensive care of paediatric intestinal transplantation as
well as their own experience. This article covers the fol-
lowing areas: the indications for intestinal transplantation,
the management of critically ill children awaiting intes-
tinal transplantation, the operative procedure, the post-
operative management. This last area deals with the
intestinal graft, the liver graft, the cardiovascular, respi-
ratory and renal support, the electrolyte and haematologic
management, the pain and infection control, the rejection
and other alterations in graft function, the nutritional
support, the problems of high stomal output, the immu-
nosuppressive treatment, the outcomes and the upcoming
challenges. The authors concluded that transplant teams
accept patients with higher morbidity and higher risks for
complications and indicate that many of these patients
would benefit from earlier referral for transplant evalua-
tion before severe complications develop.
Sedation and analgesic practices vary widely in both
adult and paediatric intensive care. However, relatively
little high quality evidence supports current paediatric
practice. Lamas et al. [11] investigated the utility of the
bispectral index (BIS), auditory-evoked responses (AEP)
and Ramsay and COMFORT clinical scales in the
assessment of sedation in critically ill children. Simulta-
neous recordings were obtained. In children in whom
neuromuscular blockade was not being used, correlation
between the four methods was moderate or good. How-
ever, only BIS and AEP were found to be potentially
reliable in those children who were both sedated and
subject to neuromuscular blockade. The authors con-
cluded that their results support the finding that the
clinical scales do not evaluate the level of sedation
accurately in critically ill children with neuromuscular
relaxation, leading to a higher risk of over or under-
sedation. They suggest that in these children, BIS and the
AEP index methods may provide a better assessment of
the level of sedation. However, they caution that lack of
correlation between these two methods in children with
neuromuscular relaxation and the absence of a reference
method to evaluate sedation in the relaxed patient means
that their results must be interpreted carefully. Further
studies are needed.
Recently, Akcan-Arikan et al. [12] have described a
modified version of the RIFLE criteria for paediatric
patients (pRIFLE). Their proposed pRIFLE criteria are
based on a decrease in estimated creatinine clearance
(eCCL),and urine output is based on body weight. Plo¨tz
et al. [13] independently evaluated the pRIFLE criteria in
a cohort of 103 children in a European PICU. Sixty
children (58%) developed acute kidney injury (AKI)
according to pRIFLE criteria of whom six required renal
replacement therapy. The authors conclude that pRIFLE
criteria may guide the early identification of patients at
risk of AKI and therefore guide early initiation of therapy,
with potential to avoid progress from ‘risk’ to injury’.
Hoover and colleagues reported a series of 26 children on
ECMO for respiratory failure who received CVVH for
[24 h and compared these to ECMO/non-CVVH case-
matched control children. Significant findings included a
faster time to desired caloric intake and reduced furose-
mide use in CVVH treated children. Although no obvious
survival benefit related to use of CVVH was demon-
strated, the association of CVVH on ECMO with
improved fluid balance and nutritional management was
compelling.
Performing optimal cardiovascular monitoring in
critically ill children is a considerable challenge. The
Journal published four papers in 2008 which address
various aspects of this challenging field. Durand et al. [14]
investigated whether the measurement of respiratory
variations in aortic blood flow velocity (D V peak Ao),
systolic arterial (D SAP) pressure and pulse pressure
(D PP) could accurately predict fluid responsiveness in
ventilated children. Standardised volume challenges were
given to 26 children with preserved ventricular function.
Aortic blood flow was analysed by transthoracic pulsed
Doppler. Whilst a positive correlation was found between
D V peak Ao and volume expansion-induced gain in
stroke volume, measurements of D SAP pressure and
D PP were of little value in predicting responses to fluid
augmentation in ventilated children. In a preliminary
study, Knirsch et al. [15] compared the measurement of
cardiac output using the Ultrasound Cardiac Output
Monitor (USCOM) with pulmonary artery catheter-
derived thermodilution cardiac output in a group of 24
children undergoing cardiac catheterization. The main
finding was that cardiac output measured with USCOM
did not reliably represent absolute values measured by
pulmonary artery catheter thermodilution, with a mean
percentage error higher than 30%. The limitations of
transthoracic pulsed Doppler cardiac output measurement
in comparison to cardiac output measurement by the
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thermodilution technique has been recognized [16]. A
number of user-dependent technical factors have been
shown to influence ultrasound-derived measurements in
other studies in a variety of situations. In addition, pos-
sible inaccuracy in algorithm-derived aortic valve
diameter used in calculation for cardiac output from flow
can introduce systematic error. Many of these limitations
are negated if serial measurements are used to derive
trends in aortic flow rather algorithm-derived ‘absolute’
cardiac outputs. Frey et al. [17] brought clarity to the
interpretation of aspects of the photoplethysmographic
wave which is displayed by most pulse oximeters. They
demonstrate that it may be used to derive additional
haemodynamic information in some selected situations
when, for instance, arterial blood pressure monitoring is
not available. The advantages of this method are its
widespread use, non-invasiveness and continuity. The
authors suggest that haemodynamic deterioration, whe-
ther suddenly occurring or slowly evolving over time,
may be detected by this method. There is only minimal
reference to photoplethysmography monitoring in the
paediatric literature.
Three studies published in 2008 relate to aspects of the
care of children undergoing cardiac surgery using car-
diopulmonary bypass. Tissie`res et al. [18] described the
use of the biomarker n-terminal brain natriuretic peptide
(N-proBNP) and troponin I in 20 children following
valvular surgery. Their results demonstrated that
N-proBNP was superior to troponin I in reflecting clinical
and echocardiographic postoperative recovery. Further-
more the authors suggest that preoperative N-proBNP
reflected postoperative myocardial functional capacity,
thus potentially helping in the early identification of
patients who are at risk of chronic cardiac dysfunction.
Another biomarker, plasma angiopoetin-2 (Angpt-2), a
vascular growth factor, was found by Giuliano et al. [19]
to independently predict cardiac ICU length of stay in a
series of 48 children palliative or corrective cardiac sur-
gery. The angiopoietins are a family of vascular growth
factors that are necessary for both developmental and
pathological angiogenesis. ANGPT-2 promotes increased
vascular permeability and inflammation and has been
shown to be increased in adults with congestive heart
failure and the acute coronary syndrome. The authors
conclude that ANGPT-2 appears to be an important bio-
marker of adverse outcome following CPB. Further
studies pertaining to the role of angpt-2 in the patho-
physiology of capillary leak syndrome following CPB are
warranted. At a more practical level, the study reported by
Ross-Russell et al. [20] is a large prospective report of the
measurement of phrenic nerve latency in 310 children
before and after cardiac surgery. Phrenic nerve injury
being a relatively common and clinically important
complication of cardiothoracic surgery). The authors
ascertained an incidence of phrenic nerve injury associ-
ated with surgery of 20%. Injury was associated with an
increased duration of postoperative ventilation (20 vs.
96 h, P \ 0.001). Of particular interest in this report is
medium term follow-up which shows that one-third
children recovered function within 1 months and a further
one-third within 3 months.
Two papers recently published in the Journal shed
further light on the mechanisms of paediatric respiratory
disease. A paper by Plunkett et al. [21] addressed the
question of whether the D allele of the I/D polymorphism
of the angiotensin converting enzyme (ACE) gene is
associated with increased susceptibility to acute hypox-
aemic respiratory failure (AHRF) in critically ill children.
Previous reports have linked the D allele of the ACE gene
to susceptibity for ARDS in critically ill adults and bron-
chopulmonary dysplasia in pre-term infants. In a single
centre prospective study, AHRF developed in 13.9% of
216 critically ill children. There was no significant dif-
ference in the frequency of the D allele between patient
groups with and without AHRF. The authors suggest that
this may suggest differences in the pathogenesis of pae-
diatric AHRF and adult ARDS. Phospholipases A2 is an
enzyme widely distributed in the body and was the focus of
a report from De Luca et al. [22]. The enzyme is primarily
involved in the turnover of membrane phospholipids and
lipid digestion. In addition phospholipase A2 is involved in
inflammation pathways through the formation of eicosa-
noids and other inflammatory mediators. In the lungs the
secretory form of the enzyme (sPLA2) is produced mainly
by alveolar macrophages and secreted into the alveoli.
sPLA2 has been shown to be involved in lung inflamma-
tion and surfactant degradation and it may play a role for
sPLA2 in the development of acute respiratory distress
syndrome (ARDS). De Luca et al. provide evidence that
sPLA2 is present in high concentrations in bronchoalveolar
lavage fluid obtained from neonates with pneumonia and
hyaline membrane disease. In this study, sPLA2 levels
correlated negatively with dynamic compliance and posi-
tively with indices of poorer oxygenation. It appears
therefore that the enzyme plays a role in the pathogenesis
of respiratory failure in neonates.
Respiratory disease caused by the respiratory syncytial
virus (RSV) accounts for almost 10% of admissions to
PICU’s [23]. RSV disease is characterised by inflamma-
tion of the small airways with raised airways resistance,
air-trapping and pulmonary consolidation, disproportion-
ately effects young infants due primarily to their poor
respiratory muscle reserve. ICM recently published three
papers describing different ventilatory strategies for
infants with RSV disease. Javouhey et al. [24] used non-
invasive ventilation as their primary form of respiratory
support in 27 infants. They applied continuous positive
airway pressure (CPAP) at 5–10 cm H2O with additional
bi-level positive pressure ventilation of 12–20 cm H2O as
required. Compared to an immediately prior historical
cohort of infants with the disease, the intubation rate was
significantly lower (52 vs. 89% P \ 0.01). Berner and
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colleagues [25] adopted a different strategy, successfully
using high frequency oscillatory ventilation whilst
allowing spontaneous breathing in a group of 9 infants
with RSV. These two strategies are essentially delivering
physiologically similar therapy, maintaining spontaneous
ventilation and relying on CPAP to maintain lung volume
and reduce the work of breathing. The suggestion that
CPAP is clinically effective in RSV bronchiolitis possibly
through reduced work of breathing in babies with RSV
bronchiolitis was first made by Beasley and Jones [26] in
1981. Whilst Thia et al. [27] have recently confirmed the
utility of nasal CPAP in infants with RSV bronchiolitis,
showing that they have lower PaCO2 values, Cambonie
et al. [28] have finally shown in an elegant study that the
use of nasal CPAP rapidly unloads the respiratory mus-
cles, reducing the work of breathing, in young infants
with severe RSV bronchiolitis. Argent et al. [29]
addressed similar issues in two related papers investi-
gating the mechanics of breathing in children with severe
croup and the effect of nebulization of epinephrine on
measures of airway obstruction [30]. Respiratory
mechanics were studies in 20 infants with severe croup.
Patients were found to maintain minute ventilation by
means of large increases in mean intrathoracic pressure
required to overcome inspiratory flow limitation. Nebu-
lised epinephrine was found to result in short-lived
improvement in some but not all patients with croup. Both
inspiratory and expiratory airway resistance fell in
patients responding to nebulised epinephrine. Oesopha-
geal pressures in both studies were measured via a feeding
tube and were found to be satisfactory for quantification
of the acute response to nebulised epinephrine whereas
flow measurements were unhelpful.
Finally two clinical reports address areas of the man-
agement of acute respiratory failure in children where
significant differences from adult practice are evident.
Pathan et al. [31] reported a series of 124 children cate-
gorised as receiving ‘paediatric extra-corporeal life
support’ in a single institution from the inception of their
ECLS programme in July 1992 until December 2005.
Clinical selection criteria operated during the study were
those of severe respiratory failure failing to respond to
conventional management and in whom recovery was
believed to be reasonably possible. Survival to hospital
discharge was 62 with 59% surviving to 1 year. Severity
of pulmonary dysfunction pre-ECMO and the presence of
shock predicted higher risk of mortality. Kneyber et al.
[32] raise the important question of whether we know the
true incidence of the acute respiratory distress syndrome
in children, or whether it is under-recognised. They ret-
rospectively reviewed 533 mechanically ventilated
children admitted to two regional Dutch paediatric ICU’s.
Chest radiographs were screened for the presence of
bilateral infiltrates, PaO2/FiO2 ratios calculated and left
ventricular dysfunction ruled out by echocardiography.
Forty-one (7.7%) of children met criteria for ARDS
giving a population-based incidence of ARDS of 2.2 per
100,000 per year. The incidence of paediatric ARDS is
low compared to adults, but the authors suggest that many
cases of ARDS are categorised by their underlying dis-
eases such as viral infections, leading to significant under-
reporting of ARDS. This may be particularly important
when planning randomised –controlled trials, as signifi-
cant underestimation of the effected population could lead
to erroneous trial designs or abandonment of trials at the
planning stage due to perceived difficulty in recruiting
subjects in a timely and cost-effective manner. Bachmann
et al. [33] investigated the level of adoption of paediatric
ventilation technologies from the participants at two
international conferences. The authors used the approach
of Rogers’ which addresses both differences among
individuals and characteristics of the innovation [34]. The
authors concluded that whilst evidence of outcomes is the
most relevant factor for assessment of potentially bene-
ficial technologies, other factors that encourage adoption
of mediocre technologies, or that retard adoption of
potentially beneficial technologies, must be understood
and acknowledged.
Ethical and legal issues in clinical research
In a concise review, Truog [35] reminds us the specific-
ities and issues in paediatric clinical research. Universal
requirements for ethical research are on one hand the
respect of subject’s autonomy and on the other the pro-
tection against harm (the risk-benefit ratio). Respect of
autonomy for a child under 18 implies that investigators,
whenever possible, seek his–her assent, besides the
parental authorization. Protection is achieved via a drastic
limitation of the risks children can be exposed during a
trial: in the US, the threshold is a ‘‘minimal risk’’ for
healthy children and a ‘‘minor increase over minimal
risk’’ for diseased ones. Then, Dr Truog proposes a three-
step approach of evaluation of paediatric research proto-
cols. The basic concept here is the so-called ‘‘component
analysis’’: the research protocol has to be broken in sev-
eral components, those part of standard care and those
which are necessary for research, in addition to care. Each
of these components are separately analysed in terms of
risk/benefit balance. However, appreciation of ‘‘minimal
risk’’ is always debatable, and it is the essential role of the
Research Ethics Committee (RECs, or IRBs in the US) to
define it on a case to case basis.
Minneci et al. [36] review a few recent randomized
clinical trials performed on severely ill patients (the
ARMA trial comparing a low and a lage Vt in ARDS, the
trial assessing the effect of growth hormone in ICU
patients and the TRICC trial, on the level of blood trans-
fusion, also in ICU patients) and emphasise the crucial
importance of the control group. They convincingly show
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that most of the controversies which followed the
publication of some of them stemmed from the inappro-
priate design of control groups. A well designed control
group has two main functions: the first one is to protect the
patients enrolled in the trial, and the second is to guarantee
the external validity of the conclusions of the research. If
the new therapy is to replace the existing standard, it has
to have been tested against this standard. Authors’ rec-
ommendations are that a control group should not be
historical, needs to represent current care and should be
enrolled along with the new treatment group. Of course, in
all large trials involving severely ill patients, a DSMB will
monitor safety by comparing the intervention group to this
control group. Special difficulties are commonplace in
critical care research: patients populations are frequently
heterogeneous, syndromes are dealt with, instead of dis-
eases (septic shock, ARDS.), many treatments are
delivered with titration: Vt, PEEP, catecholamines, blood
transfusion, making the design of a control group
extraordinary arduous (one size does no fit all.).
Zamperetti and Latronico [37] give a rather grim view
of the regulatory aspects of clinical research in Italy.
Basically, directive 2001/20/EC has been literally trans-
lated and transposed in the Italian legislation, thus
creating a ‘‘legal representative’’, which has not been
defined, at the difference of nearly all EU member states.
In consequence, decisions for any specific protocols
depend on local REC, with no coordination or common
guidelines. Similarly, a waived or deferred consent in
emergency research may or may not be possible,
depending of the local REC, which may base its decision
on directive 2001, which prohibits it, or the Oviedo
Convention, which makes it possible.
A clear description of the Convention of Human
Rights and Biomedicine (Oviedo) of the Council of
Europe is provided by Elmar Doppelfeld [38]. The
mechanisms by which states and governments, members
or not of the EU, sign and ratify the conventions and
protocols produced by the Council of Europe are descri-
bed, as well as the links between the European
Commission and the Council (not obvious to all.). Con-
cerning research on severely ill patients (a vulnerable
population), special provisions are written in the Addi-
tional Protocol. Conditions for waiving consent
(emergency) and for designation of surrogate decision-
makers in case of incapacity are specified. Research on
incompetent persons when no direct benefit is provided is
possible, under some specific provisions.
End of life issues
Charles Sprung et al. [39] published in ICM their seventh
paper derived from the huge Ethicus database. This study
has demonstrated a large gradient from Northern to
Southern regions in Europe as to the end of life decisions
in ICUs. It was certainly tempting to see whether physi-
cian’s values could explain these discrepancies. Clearly,
the lesser degree of end of life decisions in the South
corresponds to more paternalistic views, as expressed by a
more frequently cited ‘‘unresponsiveness to therapy’’, a
lesser degree of documentation of their decisions and
also a lesser consideration for patients’ ‘‘best interest’’.
However, all investigators, irrespectively of their
location, gave a low priority to patient or family request.
The authors conclude that ‘‘.there is room (in Europe)
for greater engagement with patients and their families
to promote patient autonomy in the end of life
decision-making process’’!
End of life decisions are influenced by the religious
affiliation of physicians, despite the delimitation of reli-
gion from ‘‘acculturation’’ is not always clear-cut. This
was another important demonstration by the Ethicus study
[40]. Bulo¨w et al. [41] review the world’s major religions’
points of view on end of life decisions in the ICU. The
Jewish perspective gives a fascinating insight into a new
Israeli law which deals with the prohibition by Halacha of
withdrawing mechanical ventilation. Surprisingly enough,
the Islamic perspective is not far from the catholic tra-
dition (the moral of intention, for instance), but the
authors take the precaution to indicate that in different
countries, ‘‘recognized religious scholars’’ may have the
last word.
‘‘Death rattle’’ is a common occurrence after ‘‘termi-
nal’’ extubation, at the end of life. It may destabilize
families and jeopardize an otherwise well conducted
withdrawal of life support in the ICU. Erwin Kompanje
et al. [42] provide an excellent overview of the phe-
nomenon and give guidelines on how to prevent and to
treat it. This is probably one of the most useful recom-
mendations in a crucial subject, though usually ignored.
The ICM series on national legislations on end of life
in ICUs, which started in 2006, continued in 2008 with
Austria [43], along with the guidelines produced by the
Austrian Association of Intensive Care Medicine [44] and
Spain [45].
Cabre et al. [45] have described the legal framework
for end of life decision in Spain. As in other European
countries, the Spanish society is currently concerned by
controversies as to limitation of care in emergency
departments or ICUs, a debate obscured by the absence of
a clear delimitation between euthanasia and the with-
drawal of life support. It is good news to learn that the
Court of Justice of Madrid finally cleared the physicians
involved in the ‘‘Legane´s case’’ [46] from any wrongdo-
ing. A very interesting initiative, which should be
replicated elsewhere, is the choice of end of life decisions
as an indicator of good quality of care by the Spanish
society of critical Care, the SEMICYUC.
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Servillo and Striano [47] tell us how in Italy, as in
Spain, end-of-life care gives fierce debates, further
enhanced by the strong influence of the Catholic Church
in such matters. Dr Riccio, an anaesthetist involved in the
Welby case has also been relaxed by justice. The debate is
now focused on the introduction in the Italian law of
‘‘advanced directives’’. As in other countries where laws
are mute on end of life decisions, the role of professional
societies (the SIAARTI in Italy) is crucial in guiding
physicians and in protecting them occasionally.
Outcome research and critical care organization
Sexual dysfunction seems to be highly prevalent not only
in the community, but also after critical illness. Although
patients report sexual function to be important, symptoms
of sexual dysfunction after major illness are seldom
evaluated by medical practitioners. Ulvik et al. [48] thus
studied sexual dysfunction in trauma patients 3–8 years
after discharge from the ICU, using a questionnaire. The
cohort comprised of 325 consecutive trauma patients over
18 years of age admitted to their ICU in the period 1998–
2003, of which 210 were eligible. The response rate was
with 74% highly satisfactory. Patients were asked to
describe their sexual life both, prior to the ICU admission
and presently. Half of the patients reported sexual func-
tion to be unchanged, 41% impaired, and 9% even to be
better than before the trauma. Erectile dysfunction was
found to contribute in 27% of men younger than 40 years
and 51% of men 40 years or older. Age, being single,
Injury Severity Score, and depression were associated
with a poor sexual function. The authors concluded that
due to the high incidence and also the possible impact on
individual quality of life, sexual function should be reg-
ularly evaluated at least in trauma patients.
The SAPS 3 risk-adjustment system, developed from a
world-wide multicenter study, has been published in
2005. As for all severity of illness systems, external val-
idation studies are needed to proof the prognostic
performance in settings different than the one the score
has been developed from. Ledoux et al. [49] undertook a
prospective study in their institution to evaluate the per-
formance of SAPS 3 and to compare it to two other
systems, namely APACHE II and SAPS II. They included
802 consecutively to the ICU admitted patients over an 8-
month period. With respect to discrimination, APACHE
II performed worse than SAPS II and SAPS 3 models.
Calibration was unsatisfactory again for APACHE II and
for the general SAPS 3 model, whereas it was satisfactory
for SAPS II and the SAPS 3 model with the Central
European equation. The authors concluded, that the SAPS
3 admission score and its model for Central and Western
Europe was more discriminative and better calibrated
than APACHE II, but it was not significantly better than
the SAPS II. Since this study presents as a single centre
study with a low patient number, the results have to be
viewed with caution. Multicenter studies with higher
patient numbers are required to determine the prognostic
ability of a risk-adjustment system.
Intra-abdominal hypertension (IAH) has only in the
past decade received attention as a potential source of
problems for critically ill patients. Several recent studies
have highlighted the possible impact of increased
intra-abdominal pressure on renal function. Dalfino et al.
[50] studied the relationship between IAH and acute renal
failure (ARF) in critically ill patients. They included all
patients who were consecutively admitted during a
6-month period. IAH was defined as a IAP [ = 12 mmHg
in at least two consecutive measurements performed at
24-h intervals. ARF was defined according to the failure
class of the RIFLE criteria. Almost a third of their patients
developed IAH. ARF developed in 19% of their patients,
with a significant difference between the two groups:
43.2% in the IAH versus 8.1% in the non-IAH group
(P \ 0.05). Shock and low abdominal perfusion pressure
were predictive factors for the development of ARF. A
cut-off point of 12 mmHg had the best predictive power
for the development of ARF. Although raw hospital
mortality was significantly higher in patients with IAH,
risk-adjusted mortality rate was not different between the
two groups. The authors concluded, that IAH is clearly an
independent and strong predictor for the development of
ARF. However, the contribution of impaired systemic
hemodynamics should also be taken into account.
The impact on mortality of early coagulation disorders
after severe burn injury was addressed by Lavrentieva
et al. [51]. In this single centre prospective study con-
ducted on 45 patients with severe thermal burn injury the
28-day mortality rate was 33%. The presence of overt
DIC was related to mortality (OR = 0.1). Antithrombin,
protein S, plasminogen activator inhibitor 1, and SOFA
score on day 3, protein C on day 5, and thrombin/anti-
thrombin complexes on day 7 revealed a good prognostic
value for ICU mortality. The authors concluded that the
severe thermal injury is associated with the early activa-
tion of coagulation cascade, presence of DIC, organ
failure, and increased mortality.
Bedside adherence to clinical practice guidelines may
influence the outcome. The dissemination of medical
knowledge is essential and practice surveys are important
to assess practices of health-care professionals and
develop strategies for more effective actions.
The TECLA study [52] with a multicenter, 1-day cross-
sectional design assessed adherence to clinical recom-
mendations for three interventions routinely used in critical
care medicine. A total of 419 patients hospitalized in the 44
participating ICUs in 4 countries were enrolled. Red blood
cell transfusion (n = 29) was performed appropriately in
22 patients (76%), while among the 390 patients who
received no transfusion 4 (1%) had a valid indication.
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Setting of tidal volume in acute respiratory distress
syndrome, assessed in 45 patients, was deemed appropriate
in 37 cases (82%). Prescription of stress ulcer prophylaxis
(n = 128) was appropriate in only 24 patients (19%), while
among the 268 patients who were not treated 28 (10%) had
an indication. The survey concluded that the implementa-
tion of recommendations varies across different domains of
care, being suboptimal in some contexts.
Wheeler et al. [53] carried out an audit to quantify the
variability in the concentration of drug infusions prepared
in an adult intensive care unit. They also established whe-
ther there was a relationship between the quality of syringe
labelling and drug preparation. They collected 149
discarded syringes containing midazolam, insulin, norepi-
nephrine, dopamine, potassium or magnesium. Residual
solutions were sampled, concentrations were measured, and
syringe labels were awarded a score for labelling quality
based on an 11-point scale. The majority of the infusions
differed from the expected concentration by more than
10%. Magnesium infusions were least likely to be properly
labelled. There was a positive correlation between quality
of syringe labelling and drug preparation. After the intro-
duction of a new electrolyte prescription chart, magnesium
and potassium preparation significantly improved but there
was still substantial variability. The authors conclude by a
plea for the use of pre-prepared syringes or standardized
drug preparation and labelling systems.
Scientific societies have published position papers
recommending certain critical care pharmacy activities. In
a brief report LeBlanc et al. [54] described the activities
of international pharmacists who had a significant portion
of their duties dedicated to critical care to increase the
awareness of pharmacist roles to the critical care team.
The authors analyzed data obtained in a website based
survey. The majority of respondents (74.4% of a total of
168 pharmacists) attended medical rounds and 54.8%
were involved in research. The majority of pharmacists
(72.6%) were involved in drug monitoring (mainly ami-
noglycosides and vancomycin). A few prepared
intravenous medications or total parenteral nutrition, 13
and 8.4%, respectively. Authors conclude that critical
care pharmacists participate in a wide range of activities
and they expect that the involvement of the pharmacist in
critical care teams will increase.
In a prospective multicentre study, Takala et al. [55]
tested the feasibility of three software-driven critical care
protocols. They applied software-driven protocols for
cardiovascular management, sedation, and weaning dur-
ing the first 7 ICU-days in 174 cardiac surgery and 41
septic patients. Protocol use was discontinued in 12% of
patients by the treating clinician and in 6% for technical/
administrative reasons. This study advocates that multiple
software-driven treatment protocols can be simulta-
neously applied with high acceptance and rapid
achievement of primary treatment goals (Initial hemody-
namic stability, Sedation targets, Weaning time).
In a prospective observational study, Perren et al. [56]
assessed whether cross-checking of the physician ICU
transfer report by ICU nurses may reduce transfer report
errors. About 123 patients were randomly selected at
discharge from the ICU and physician ICU transfer
reports were cross-checked by nurses using defined
review criteria. About 76 (62%) transfer reports were
affected by at least one error which was classified as
simple (81%), serious (14%) or critical (5%). Thirty-five
(28%) transfer reports were considered potentially
harmful. Among 305 intercepted errors, 247 were pre-
scription errors (26% of all prescriptions), 45 involved
proposed procedures, and 13 were deficient in updating
diagnoses. Only the number of medications included in
the transfer report was associated with the occurrence of
at least one critical/serious error.
Calzavacca et al. [57] identified risk factors for mor-
tality in 228 patients receiving one or more Medical
Emergency Team reviews during daytime hours over a
1-year-period. Delayed Medical Emergency Team activa-
tion and not-for resuscitation orders were the only factors
that showed an independent association with mortality.
Ospina et al. [58] in a comprehensive literature review
analysed which monitoring techniques have been shown
to improve outcomes in ICU patients, concluding that
there is no broad evidence that any form of monitoring
improves outcomes in the ICU. Through an highly
sensitive search in the Cochrane Central Register of
Controlled Trials (CENTRAL) and MedLine, for pro-
spective, randomized controlled trials (RCTs) conducted
in adult patients in the ICU and the operating room (major
surgical procedures), the authors focused on the impact of
monitoring on outcome. Of 4,175 potential articles, 67
evaluated the impact of monitoring. Forty studies were
related to hemodynamic monitoring, 17 to respiratory
monitoring, and 10 to neurological monitoring. Positive
non-mortality outcomes were observed in 17 of 40
hemodynamic studies, 11 of 17 respiratory, and in all 10
neurological studies. Mortality was evaluated in 31
hemodynamic studies, but a beneficial impact was dem-
onstrated in only 10. For respiratory monitoring, seven
studies evaluated mortality, but only three of them
showed an improved outcome.
Clinicians–family interactions and nurse’s burnout
In a qualitative study, Mc Adam et al. [59] described
the contributions to care that 25 family members per-
form while their loved one is at high risk of dying in
the ICU. Interviews with relatives were recorded and
three independent raters coded transcripts. Work roles
that family members take on while their loved one is in
the ICU consisted of active presence, patient protector,
facilitator, historian, coach, and voluntary caregiver.
These multiple roles performed by relatives are often
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not valued or go unrecognized by ICU health care
providers.
Giannini et al. [60] investigated visiting policies in
257 Italian ICUs. Median daily visiting time was 60 min
and 55% of ICUs had one daily visiting slot. There were
restrictions on number (92% of units) and type (17%) of
visitors and on child visits (69%). Policies were not
modified for child patients in 9% of ICUs, nor for a dying
patient in 21%. No waiting room was provided by 25% of
ICUs. Gowning procedures were required for visitors in
95% of units. In 66% of ICUs informative material on the
unit was provided to the family on patient admission.
Regional area and volume of admissions significantly
influenced visiting hours. One-third of ICUs were being
rethinking their policies.
Verdon et al. [61] evaluated the level of burnout in 97
members of the nursing team. 28% showed a high level of
burnout. Among concerns reported by the nurses, only the
lack of patients’ co-operation, the organization of the
service and the rapid patient turnover were independently
associated with a high level of burnout.
Sedation and pharmacology
Weinert and Sprenkle [62] assessed the impact of sedative
exposure on ICU recall and symptoms of posttraumatic
stress disorder in patients receiving mechanical ventila-
tion. They interviewed 149 patients who required [36 h
of mechanical ventilation 2 months after ICU discharge.
Eighty patients were also interviewed at 6 months. ICU
recall was greater for events occurring at the end of
critical illness; however, 18% of subjects had amnesia for
the entire ICU course. Posttraumatic stress disorder
prevalence was 17% at 2 months and 15% at 6 months.
Recall of a delirious memory during critical illness was
associated with more severe posttraumatic stress symp-
toms. Neither ICU recall nor posttraumatic stress
symptoms were associated with the intensity of sedative
administration during mechanical ventilation. Posttrau-
matic stress symptoms were lowest in patients either the
most awake during mechanical ventilation or the least
awake. In a prospective, randomised, single-blinded,
controlled study, Ro¨hm et al. [63] compared sevoflurane
and propofol in terms of recovery times from sedation. A
total of 70 patients after elective coronary artery bypass
graft surgery received either sevoflurane (n = 35) or
propofol (n = 35) for short-term postoperative sedation
in the ICU. Mean extubation times from termination of
sedation (the primary outcome) were significantly shorter
with sevoflurane than with propofol (22 vs. 151 min). The
length of ICU stay was comparable in both groups, but
hospital length of stay was significantly shorter in the
sevoflurane group. Costs for sedation per patient were
similar in both groups. Suchyta et al. [64] compared
mortality and discharge disposition in critically ill
patients with and without drug or alcohol dependence and
patients with and without psychiatric disorders. They
found that patients with drug or alcohol dependence were
at higher risk for ICU admission compared to the general
population. However, the prevalence of psychiatric dis-
orders was significantly lower than in the general
population. Drug or alcohol dependence predicted shorter
hospital length of stay. In a retrospective review of patient
records over 2 years in 20 French city hospitals
Lapostolle et al. [65] evaluated 838 patients with an ele-
vated serum digitalis concentration (digoxin[1.95 ng/ml
or digitoxin [ 23 ng/ml), following chronic or acute
exposure. Of these, 67 (8%) had received antidotal ther-
apy with Fab fragments. Five independent factors were
associated with the use of antidotal therapy: acute over-
dose (OR 15.74), Fab fragment availability in the hospital
(11.06), serum potassium (1.81), and heart rate (0.96).
Mortality was significantly lower in Fab-treated (6%, 4/
67) than untreated patients (15%, 117/770). The authors
concluded that antidotal therapy is underused in patients
with an elevated digitalis concentration and the use of
identical criteria for antidotal treatment after acute and
chronic poisoning should help optimize outcomes.
Miscellanea
Vandijck et al. [67] compared characteristics and out-
comes in ICU-patients with haematological malignancies
and severe sepsis/septic shock who had or had not
received recent intravenous chemotherapy. Among the
186 patients, there were 77 patients with severe sepsis and
109 with septic shock; 91 (49%) had received recent
intravenous chemotherapy. In-hospital, and 6-month
mortality rates were 45.1 versus 58.9%, and 50.5 versus
63.2% in patients with and without recent chemotherapy,
respectively. By multivariate analysis, previous chemo-
therapy was protective. After adjustment with a
propensity score for recent chemotherapy, chemotherapy
was not associated with outcome.
In a review article [66] on organ dysfunction in
hemophagocytic lymphohistiocytosis Cre´put et al. pro-
vides an overall overview on this entity and aims at
helping clinicians to maintain a high level of suspicion
regarding the diagnosis. The parts covered in this review
are: the clinical and laboratory features, the cytology and
histology aspects, the etiologies, the pathophysiology, the
prognosis and mortality, and the therapeutic approach.
The authors concluded that the management of the
hemophagocytic lymphohistiocytosis requires a multi-
disciplinary team, and the high mortality in patients with
no etiological diagnosis requires aggressive investigation
and treatment.
Payen et al. [68] assessed blood leucocytes gene pro-
filing in the course of the septic shock recovery period
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and tested the relation between encoding gene expression
and protein level in 17 septic shock patients. Gene
expression levels were studied on a dedicated microarray
of 340 genes involved in inflammatory processes. The
time-related gene expression study showed significant
changes in ten genes. Among them, S100A8 and
S100A12 had a reduced expression over time compared
with D0, whereas CD74’s expression increased. By RT-
qPCR, the S100A8 plasma levels decrease in parallel with
the gene expression decrease. The CD74 gene expression
evolution significantly correlated with HLA-DR mono-
cyte expression.
In a fascinating mini-series Foresti et al. [69] and
Bauer et al. [70] reviewed the role and pathophysiological
mechanisms of the heme oxygenase–carbon monoxide
system (HO–CO) and the challenging potential use of CO
as therapeutic agent. In the past decade, the use of CO gas
in pre-clinical experimental models of disease has
produced some remarkable data indicating that its
therapeutic delivery to mammals could alleviate inflam-
matory processes and cardiovascular disorders. However,
the inherent toxic nature of CO cannot be ignored,
knowing that inhalation of uncontrolled amounts of this
gas can ultimately lead to serious systemic complications
and neuronal derangements. From a clinical perspective, a
key question is whether a safe and therapeutically effec-
tive threshold of CO can be reached locally in organs and
tissues without delivering potentially toxic amounts
through the lung. The advent of CO-releasing molecules
(CO-RMs), a group of compounds capable of carrying
and liberating controlled quantities of CO in cellular
systems, could be a plausible alternative in the attempt to
overcome the limitations of CO gas. Although in its
infancy and far from being used for clinical applications,
the CO-RMs technology is supported by very encourag-
ing biological results.
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